Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Don Walster who wrote (855)	2/5/1998 11:16:00 PM
From: DrJerry	Respond to of 1605

Don: The studies quoted by Cardiomedics are without exception studies performed by Vasomedicals EECP device or by earlier equipment prior to its refinement in China. Cardiomedics has NO data to date with which to prove its equipment can match Vasomedical's. While they might argue that counterpulsation is counterpulsation there is adequate reason to be skeptical. For example, a major component of EECP is systolic unloading which is performed in different ways by the two machines. I suggest that one be very wary of Cardiomedic's claims until they have adequate data. Whatever you feel about Vaso and their lack of responsiveness to you inquiries, one cannot deny the fact that they are being methodically scientific about their studies. There is a meticulous data base being coordinated through the U.of Pittsburgh at present. Until Cardiomedics can match this scientific approach, I intend to be skeptical.